Medtronic (NYSE:MDT) today announced U.S. Food and Drug Administration approval of the latest product in its growing diabetes portfolio, the next generation iPro2 continuous glucose monitoring (CGM) ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the Enlite sensor for use with Medtronic’s iPro2 Professional Continuous Glucose Monitoring ...
MILAN - February 5, 2016 - A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (MDT), the global leader in medical technology, demonstrates that patients with type 2 diabetes ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Medtronic, Inc. (NYSE:MDT) today announced the Food and Drug Administration (FDA) approval of iPro ® 2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a ...
Leading medical devices player, Medtronic ( MDT) has received approval from the US Food and Drug Administration (FDA) for iPro2, a next generation Professional continuous glucose monitoring (CGM) ...
Device giant Medtronic rolled out an updated meal-logging app for its iPro2 glucose-monitoring device that can be used by physicians and patients to help keep diabetes in check. The myLog app uses ...
Medtronic has selected Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., as an exclusive distributor of selected diabetes products to primary care physicians (PCPs) in the U.S.
In a recent press release, Medtronic announced the availability of the updated iPro(TM)2 myLog app with FoodPrint(TM) Report. The iPro2 myLog app offers a simple way for clinics to import patients’ ...
Leading medical devices player, Medtronic (NYSE:MDT - News) has received approval from the US Food and Drug Administration (:FDA) for iPro2, a next generation Professional continuous glucose ...
MILAN - February 5, 2016 - A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (MDT), the global leader in medical technology, demonstrates that patients with type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results